Divergence in dimerization and activity of primate APOBEC3C
A. Gaba, M. A. Hix, S. Suhail, B. Flath, B. Boysan, D. R. Williams, T. Pelletier, M. Emerman, F. Morcos, G. A. Cisneros, L. Chelico
Abstract
The APOBEC3 (A3) family of single-stranded DNA cytidine deaminases are host restriction factors that inhibit lentiviruses, such as HIV-1, in the absence of the Vif protein that causes their degradation. Deamination of cytidine in HIV-1 (-)DNA forms uracil that causes inactivating mutations when uracil is used as a template for (+)DNA synthesis. For APOBEC3C (A3C), the chimpanzee and gorilla orthologues are more active than human A3C, and the Old World Monkey A3C from rhesus macaque (rh) is not active against HIV-1. Multiple integrated analyses determined why rhA3C was not active against HIV-1 and how to increase this activity. Biochemical, virological, and coevolutionary analyses combined with molecular dynamics simulations showed that the key amino acids needed to promote rhA3C antiviral activity also promoted dimerization. Although rhA3C shares a similar dimer interface with hominid A3C, the key amino acid contacts were different. Overall, our results determine the basis for why rhA3C is less active than human A3C, establish the amino acid network for dimerization and increased activity, and track the loss and gain of A3C antiviral activity in primates. The coevolutionary analysis of the A3C dimerization interface provides a basis from which to analyze dimerization interfaces of other A3 family members.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Loop 1 of APOBEC3C regulates its antiviral activity against HIV-1
A. A. Jaguva Vasudevan, K. Balakrishnan, … C. Münk·bioRxiv·Feb 5, 2020
- Recurrent Loss of APOBEC3H Activity during Primate Evolution
E. I. Garcia, M. Emerman·bioRxiv·May 1, 2018
- Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms
M. M. McDonnell, S. C. Karvonen, … M. Emerman·bioRxiv·Apr 6, 2021
- APOBEC3C tandem domain proteins create super restriction factors against HIV-1
M. M. McDonnell, K. H. Crawford, … M. Emerman·bioRxiv·Mar 27, 2020
- Polymorphisms in human APOBEC3H differentially regulate ubiquitination and antiviral activity
N. M. Chesarino, M. Emerman·bioRxiv·Feb 7, 2020
- Variability in HIV-1 Transmitted/Founder Virus Susceptibility to Combined APOBEC3F and APOBEC3G Host Restriction
A. Gaba, M. Yousefi, … L. Chelico·Journal of VirologyPeer-reviewed·Jan 31, 2025